Decrease in binding for the neuropeptide VIP in response to marked inflammation of the mucosa in ulcerative colitis

Annals of the New York Academy of Sciences

Volumn 1107, Issue , 2007, Pages 280-289

  Jönsson, Maria ^a   Norrgård, Örjan ^a   Hansson, Magnus ^b   Forsgren, Sture ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Colitis; Inflammation; Neuropeptides; VIP; VIP binding

Indexed keywords

NEUROPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE; BIOLOGICAL MARKER; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR;

ADULT; AGED; AUTORADIOGRAPHY; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DIGESTIVE SYSTEM INFLAMMATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; INTESTINE MUCOSA; MALE; PATHOGENESIS; PROTEIN BINDING; SIGMOID; TROPHIC ULCER; ULCERATIVE COLITIS; ARTICLE; INFLAMMATION; METABOLISM; MIDDLE AGED; PATHOLOGY; STOMACH MUCOSA;

ADULT; AGED; AGED, 80 AND OVER; AUTORADIOGRAPHY; BIOLOGICAL MARKERS; COLITIS, ULCERATIVE; FEMALE; GASTRIC MUCOSA; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTESTINAL MUCOSA; MALE; MIDDLE AGED; RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE; VASOACTIVE INTESTINAL PEPTIDE;

EID: 34648826031     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1381.030     Document Type: Conference Paper

References (20)

1. EKBLAD, E. & A.J. BAUER. 2004. Vasoactive intestinal peptide and inflammatory mediators in enteric neuronal plasticity. Neurogastroenterol. Motil. 16: 123-128.
2. GOLL, R., J.H. POULSEN, P. SCHMIDT, et al. 1994. Peptide-evoked release of amylase from isolated acini of the rat parotid gland. Regul. Pept. 26: 237-254.
3. KIM, W.K., Y. KAN, D. GANEA, et al. 2000. Vasoactive intestinal peptide and pituitary adenylyl cyclase-activating polypeptide inhibit tumor necrosis factor-alpha production in injured spinal cord and in activated microglia via a camp-dependent pathway. J. Neurosci. 20: 3622-3630.
4. QUIAN, B.F., M.L. HAMMARSTROM & A. DANIELSSON. 2001. Differential expression of vasoactive intestinal polypeptide receptor 1 and 2 mRNA in murine intestinal T lymphocyte subtypes. J. Neuroendocrinol. 13: 818-823.
5. JÖNSSON, M., Ö. NORRGÅRD & S. FORSGREN. 2005. Substance P and the neurikinin-1 receptor in relation to eosinophilia in ulcerative colitis. Peptides 26: 799-814.
6. COLLINS, S.M. 1996. The immunomodulation of enteric neuromuscular function: implications for motility and inflammation disorders. Gastroenterology 111: 1683-1699.
7. TOMITA, R., K. TANJOH, S. FUJISAKI, et al. 2000. Peptidergic nerves in the colon of patients with ulcerative colitis. Hepatogastroenterology 47: 400-404.
8. REUBI, J.C., B. WASER, A. SCHMASSMANN, et al. 1999. Receptor autoradiographic evaluation of cholecystokinin, neurotensin, somatostatin and vasoactive intestinal peptide receptors in gastro-intestinal adenocarcinoma samples: where are they really located? Int. J. Cancer 5: 376-386.
9. HÖCKERFELT, U., R. HENRIKSSON, L. FRANZÉN, et al. 1999. Irradiation induces marked immunohistochemical expression of vasoactive intestinal peptide in colonic mucosa of man. Dig. Dis. Sci. 44: 393-401.
10. KERÄNEN, U., H. JÄRVINEN, T. KIVILUOTO, et al. 1996. Substance P- and vasoactive intestinal polypeptide-immunoreactive innervation in normal and inflamed pouches after restorative proctocolectomy for ulcerative colitis. Dig. Dis. Sci. 41: 1658-1664.
11. HÖCKERFELT, U., M. HANSSON, S. GULBENKIAN, et al. 1998. Binding sites for VIP in the reorganizing mucosa of the irradiated bowel. Ann. N.Y. Acad. Sci. 11: 344-352.
12. MANTYH, P.W., M.D. CATTON, C.G. BOEHMER, et al. 1989. Receptors for sensory neuropeptides in human inflammatory diseases: implications for the effector role of sensory neurons. Peptides 10: 627-645.
13. RETTENBACHER, M. & J.C. REUBI. 2001. Localization and characterization of neuropeptide receptors in human colon. Naunyn Schmiedebergs Arch. Pharmacol. 364: 291-304.
14. OTTAWAY, C.A. 1991. Neuroimmunomodulation in the intestinal mucosa. Gastroenterol. Clin. North Am. 20: 511-529.
15. SHANAHAN, F. & P. ANTON. 1988. Neuroendocrine modulation of the immune system. Possible implications for inflammatory bowel disease. Dig. Dis. Sci. 33: 41S-49S.
16. POZO, D. & M. DELGADO. 2004. The many faces of VIP in neuroimmunology: a cytokine rather than a neuropeptide? FASEB J 18: 1325-1334.
17. LEVITE, M. & Y. CHOWERS. 2001. Nerve-driven immunity: neuropeptides regulate cytokine secretion of T cells and intestinal epithelial cells in a direct, powerful and contextual manner. Ann. Oncol. 12(Suppl 2): S19-S25.
18. GONZALEZ-REY, E. & M. DELGADO. 2005. Role of vasoactive intestinal peptide in inflammation and autoimmunity. Curr. Opin. Investig. Drugs 6: 1116-1123.
19. ABAD, C., C. MARTINEZ, M.G. JUARRANZ, et al. 2003. Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohns disease. Gastroenterology 124: 961-971.
20. NEWMAN, R., N. CUAN, T. HAMPARTZOUMIAN, et al. 2005. Vasoactive intestinal peptide impairs leukocyte migration but fail to modify experimental murine colitis. Clin. Exp. Immunol. 139: 411-420.